Table 8 Factors associated with the concordance between CG and MDRD formula for drug dosing recommendation agreement in Patients with chronic kidney disease in renal clinic of St. Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia between July – September, 2016 (n = 163)
Variables | Drug dose recommendation agreement | 95% C.I. | COR | P-value | 95% C.I. | AOR | P-value | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Yes | No | Lower | Upper | Lower | Upper | ||||||
Sr.Cr (mg/dL) | 1.2–3.5 | 83 | 15 | 1 | |||||||
>3.5 | 63 | 2 | 0.04 | 0.8 | 0.18 | 0.02 | 0.04 | 1.1 | 0.22 | 0.06 | |
Age (years) | ≤30 | 28 | 1 | 1 | |||||||
31–40 | 30 | 4 | 0.39 | 35.46 | 3.73 | 0.25 | 0.44 | 42.0 | 4.32 | 0.21 | |
41–50 | 25 | 1 | 0.07 | 18.86 | 1.12 | 0.94 | 0.07 | 19.3 | 1.13 | 0.93 | |
51–60 | 33 | 3 | 0.25 | 25.86 | 2.55 | 0.43 | 0.32 | 35.9 | 3.41 | 0.31 | |
61–70 | 22 | 3 | 0.37 | 39.28 | 3.82 | 0.26 | 0.33 | 36.6 | 3.49 | 0.30 | |
>70 | 8 | 5 | 1.78 | 172.17 | 17.50 | 0.01 | 1.22 | 121.8 | 12.17 | 0.03a | |